A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Clinical trial NCT02434497 · COMPLETED
Trial details
- NCT number
- NCT02434497
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-06
- Primary completion
- 2016-11-17
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.